Molecular Partners Ag -adr logo

Molecular Partners Ag -adr Share Price (NASDAQ: MOLN)

$3.75

0.15

(4.17%)

Last updated on

Check the interactive Molecular Partners Ag -adr Stock chart to analyse performance

Molecular Partners Ag -adr stock performance

as on August 30, 2025 at 1:28 am IST

  • Today's Low:$3.70
    Today's High:$3.75

    Day's Volatility :1.33%

  • 52 Weeks Low:$3.36
    52 Weeks High:$7.60

    52 Weeks Volatility :55.79%

Molecular Partners Ag -adr Stock Returns

PeriodMolecular Partners Ag -adrSector (Health Care)Index (Russel 2000)
3 Months
-1.06%
3.6%
0.0%
6 Months
-19.87%
-7.7%
0.0%
1 Year
-33.51%
-12.6%
0.0%
3 Years
-34.33%
10.2%
-4.1%

Molecular Partners Ag -adr Key Stats

Check Molecular Partners Ag -adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.6
Open
$3.7
Today's High
$3.75
Today's Low
$3.7
Market Capitalization
$139.5M
Today's Volume
$4.1K
52 Week High
$7.6
52 Week Low
$3.36
Revenue TTM
$681.0K
EBITDA
$-59.3M
Earnings Per Share (EPS)
$-2.23
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-49.42%

Stock Returns calculator for Molecular Partners Ag -adr Stock including INR - Dollar returns

The Molecular Partners Ag -adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Molecular Partners Ag -adr investment value today

Current value as on today

₹71,773

Returns

₹28,227

(-28.23%)

Returns from Molecular Partners Ag -adr Stock

₹33,511 (-33.51%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Molecular Partners Ag -adr Stock

200%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Molecular Partners Ag -adr Stock from India on INDmoney has increased by 200% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Molecular Partners Ag -adr

  • Name

    Holdings %

  • Suvretta Capital Management, LLC

    6.02%

  • Bvf Inc

    3.67%

  • UBS Group AG

    0.02%

Analyst Recommendation on Molecular Partners Ag -adr Stock

Rating
Trend

Sell

    9%Buy

    27%Hold

    63%Sell

Based on 11 Wall street analysts offering stock ratings for Molecular Partners Ag -adr(by analysts ranked 0 to 5 stars)

Molecular Partners Ag -adr Share Price Target

What analysts predicted

Upside of 183.41%

Target:

$10.63

Current:

$3.75

Molecular Partners Ag -adr share price target is $10.63, a slight Upside of 183.41% compared to current price of $3.75 as per analysts' prediction.

Molecular Partners Ag -adr Stock Insights

  • Price Movement

    In the last 6 months, MOLN stock has moved down by -25.4%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 2.73M → 681.0K (in $), with an average decrease of 49.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -11.23M → -20.39M (in $), with an average decrease of 35.5% per quarter
  • MOLN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 103.9%
  • MOLN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 152.0%
  • Price to Sales

    ForMOLN every $1 of sales, investors are willing to pay $197.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Molecular Partners Ag -adr Technicals Summary

Sell

Neutral

Buy

Molecular Partners Ag -adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Molecular Partners Ag -adr Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Molecular Partners Ag -adr logo
6.23%
-19.87%
-33.51%
-34.33%
-80.34%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Molecular Partners Ag -adr

Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in preclinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and Radio-DARPin Therapy to treat ovarian disease. In addition, the company develops MP0621, a molecular partners' first Switch-DARPin program, which is in preclinical trial designed to induce killing of hematopoietic stem cells (HSCs) as a next-generation conditioning regimen for HSC transplantation (HSCT); and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.
Organization
Molecular Partners Ag -adr
Employees
153
CEO
Dr. Patrick Amstutz Ph.D.
Industry
Services

Key Management of Molecular Partners Ag -adr

NameTitle
Dr. Patrick Amstutz Ph.D.
Co-Founder, CEO, Member of Management Board & Director
Dr. Michael Tobias Stumpp Ph.D.
Co-Founder, Executive VP of Projects & Member of Management Board
Mr. Robert Hendriks
Senior VP of Finance
Mr. Alexander Zurcher
COO & Member of Management Board
Ms. Renate Gloggner
Executive VP of People & Community and Member of Management Board
Dr. Philippe Legenne M.B.A., M.D.
Chief Medical Officer & Member of the Management Board
Mr. Daniel Steiner Ph.D.
Senior Vice President of Research & Technology
Mr. Seth D. Lewis
Senior Vice President of Investor Relations, Communications & Strategy
Mr. Michael Pitzner
General Counsel, Compliance Officer, Senior VP Legal & Business Development
Dr. Pamela A. Trail Ph.D.
Strategic Consultant

Important FAQs about investing in MOLN Stock from India :

What is Molecular Partners Ag -adr share price today?

Molecular Partners Ag -adr share price today is $3.75 as on at the close of the market. Molecular Partners Ag -adr share today touched a day high of $3.75 and a low of $3.70.

What is the 52 week high and 52 week low for Molecular Partners Ag -adr share?

Molecular Partners Ag -adr share touched a 52 week high of $7.60 and a 52 week low of $3.36. Molecular Partners Ag -adr stock price today i.e. is closed at $3.75, lower by 50.66% versus the 52 week high.

How to invest in Molecular Partners Ag -adr Stock (MOLN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Molecular Partners Ag -adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Molecular Partners Ag -adr Shares that will get you 0.4000 shares as per Molecular Partners Ag -adr share price of $3.75 per share as on August 30, 2025 at 1:28 am IST.

What is the minimum amount required to buy Molecular Partners Ag -adr Stock (MOLN) from India?

Indian investors can start investing in Molecular Partners Ag -adr (MOLN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Molecular Partners Ag -adr stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Molecular Partners Ag -adr share’s latest price of $3.75 as on August 30, 2025 at 1:28 am IST, you will get 2.6667 shares of Molecular Partners Ag -adr. Learn more about fractional shares .

What are the returns that Molecular Partners Ag -adr has given to Indian investors in the last 5 years?

Molecular Partners Ag -adr stock has given -80.34% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?